Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulm ...

A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

A dipstick urine test and a mobile app may help predict disease exacerbations in COPD patients as much as a week in advance, ...

Patients with COPD who have mucus plugs identified via CT scans are associated with greater risks for acute exacerbations of their disease.

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. There were some important ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%.

Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.